Obesity Drugs Enjoy a Much-Needed Winning Str...

Realizing President Donald Trump’s plan for a US-led revival of Venezuela’s beleaguered oil industry could be a years-long and challenging process costing upwards of $100 billion. Years of corruption, underinvestment, fires and thefts have left the nation’s crude infrastructure i ...  Afficher plus

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Venezuela Regroups With New President, Old Repression Tactics Venezuela’s government is reasserting itself after the capture of Nicolás Maduro, swearing in Delcy Rodríguez as acting president and flashing warni ...  Afficher plus

Bloomberg Opinion Columnist and Former New York Fed President William Dudley discusses the outlook for the labor market and Fed monetary policy. David Riley, BlueBay Asset Management Chief Investment Strategist, says the market is underpricing the Fed. Danny Blanchflower, Dartmou ...  Afficher plus

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Afficher plus

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Afficher plus

One of the most iconic brands in financial television returns for today's issues and today's world. This week's Wall Street Week features David Westin's interviews with Former Council of Economic Advisers Chairman Glenn Hubbard, Equity Group Investments Founder & Chairman Sam Zel ...  Afficher plus